209 related articles for article (PubMed ID: 32271143)
1. Intraneural perineurioma in neurofibromatosis type 2 with molecular analysis.
White B; Belzberg A; Ahlawat S; Blakeley J; Rodriguez FJ
Clin Neuropathol; 2020; 39(4):167-171. PubMed ID: 32271143
[TBL] [Abstract][Full Text] [Related]
2. Association of intraneural perineurioma with neurofibromatosis type 2.
Pendleton C; Spinner RJ; Dyck PJB; Mauermann ML; Ladak A; Restrepo CE; Baheti S; Klein CJ
Acta Neurochir (Wien); 2020 Aug; 162(8):1891-1897. PubMed ID: 32529330
[TBL] [Abstract][Full Text] [Related]
3. Soft tissue perineurioma in a patient with neurofibromatosis type 2: a tumor not previously associated with the NF2 syndrome.
Pitchford CW; Schwartz HS; Atkinson JB; Cates JM
Am J Surg Pathol; 2006 Dec; 30(12):1624-9. PubMed ID: 17122521
[TBL] [Abstract][Full Text] [Related]
4. Recurrent Genomic Alterations in Soft Tissue Perineuriomas.
Carter JM; Wu Y; Blessing MM; Folpe AL; Thorland EC; Spinner RJ; Jentoft ME; Wang C; Baheti S; Niu Z; Mauermann ML; Klein CJ
Am J Surg Pathol; 2018 Dec; 42(12):1708-1714. PubMed ID: 30303818
[TBL] [Abstract][Full Text] [Related]
5. [Intraneural perineurioma: clinical and morphological characteristics and a molecular genetic study of the neurofibromatosis type 2 gene].
Shelekhova KV; Sima R; Orlov AIu; Kozakov DV; Michal M
Arkh Patol; 2008; 70(4):20-2. PubMed ID: 18807521
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous sclerosing perineurioma with cryptic NF2 gene deletion.
Sciot R; Dal Cin P; Hagemeijer A; De Smet L; Van Damme B; Van den Berghe H
Am J Surg Pathol; 1999 Jul; 23(7):849-53. PubMed ID: 10403310
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Pathology of Tumors of Peripheral Nerve.
Belakhoua SM; Rodriguez FJ
Neurosurgery; 2021 Feb; 88(3):443-456. PubMed ID: 33588442
[TBL] [Abstract][Full Text] [Related]
8. Neurofibromatosis-related tumors: emerging biology and therapies.
Karajannis MA; Ferner RE
Curr Opin Pediatr; 2015 Feb; 27(1):26-33. PubMed ID: 25490687
[TBL] [Abstract][Full Text] [Related]
9. What is new in intraneural perineurioma?
Lenartowicz KA; Smith BW; Jack MM; Wilson TJ; Klein CJ; Amrami KK; Spinner RJ
Acta Neurochir (Wien); 2023 Nov; 165(11):3539-3547. PubMed ID: 37684428
[TBL] [Abstract][Full Text] [Related]
10. Advances in the treatment of neurofibromatosis-associated tumours.
Lin AL; Gutmann DH
Nat Rev Clin Oncol; 2013 Nov; 10(11):616-24. PubMed ID: 23939548
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activation in neurofibromatosis 2-associated and sporadic schwannomas.
Sirén V; Antinheimo JP; Jääskeläinen J; Böhling T; Carpén O; Vaheri A
Acta Neurochir (Wien); 2004 Feb; 146(2):111-8. PubMed ID: 14963743
[TBL] [Abstract][Full Text] [Related]
12. Intraneural reticular perineurioma of the neck.
de La Jarte-Thirouard AS; Jacquier I; de Saint-Maur PP
Ann Diagn Pathol; 2003 Apr; 7(2):120-3. PubMed ID: 12715338
[TBL] [Abstract][Full Text] [Related]
13. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.
Caltabiano R; Magro G; Polizzi A; Praticò AD; Ortensi A; D'Orazi V; Panunzi A; Milone P; Maiolino L; Nicita F; Capone GL; Sestini R; Paganini I; Muglia M; Cavallaro S; Lanzafame S; Papi L; Ruggieri M
Childs Nerv Syst; 2017 Jun; 33(6):933-940. PubMed ID: 28365909
[TBL] [Abstract][Full Text] [Related]
14. Malignant peripheral nerve sheath tumor: Transformation in a patient with neurofibromatosis type 2.
Agresta L; Salloum R; Hummel TR; Ratner N; Mangano FT; Fuller C; McMasters RL; Pater L; Jones BV; Szabo S; Pressey JG
Pediatr Blood Cancer; 2019 Feb; 66(2):e27520. PubMed ID: 30408304
[TBL] [Abstract][Full Text] [Related]
15. Multiple schwannomas: schwannomatosis or neurofibromatosis type 2?
Seppälä MT; Sainio MA; Haltia MJ; Kinnunen JJ; Setälä KH; Jääskeläinen JE
J Neurosurg; 1998 Jul; 89(1):36-41. PubMed ID: 9647170
[TBL] [Abstract][Full Text] [Related]
16. Microscopic intraneural perineurial cell proliferations in patients with neurofibromatosis type 1.
Agaimy A
Ann Diagn Pathol; 2014 Apr; 18(2):95-8. PubMed ID: 24461704
[TBL] [Abstract][Full Text] [Related]
17. Mouse models of neurofibromatosis.
McClatchey AI; Cichowski K
Biochim Biophys Acta; 2001; 1471(2):M73-80. PubMed ID: 11342186
[No Abstract] [Full Text] [Related]
18. Segmental neurofibromatosis type 2: discriminating two hit from four hit in a patient presenting multiple schwannomas confined to one limb.
Castellanos E; Bielsa I; Carrato C; Rosas I; Solanes A; Hostalot C; Amilibia E; Prades J; Roca-Ribas F; Lázaro C; Blanco I; Serra E;
BMC Med Genomics; 2015 Jan; 8():2. PubMed ID: 25739810
[TBL] [Abstract][Full Text] [Related]
19. Peripheral nerve sheath tumors in Neurofibromatosis Type 2: Surgical and histopathologic features.
Mehta GU; Huynh H; Lekovic GP
Clin Neurol Neurosurg; 2020 Mar; 190():105649. PubMed ID: 31881415
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis, Management, and New Therapeutic Options in Childhood Neurofibromatosis Type 2 and Related Forms.
Ruggieri M; Praticò AD; Evans DG
Semin Pediatr Neurol; 2015 Dec; 22(4):240-58. PubMed ID: 26706012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]